The Telmisartan Renoprotective Study from Incipient Nephropathy to Overt Nephropathy - Rationale, Study Design, Treatment Plan and Baseline Characteristics of the Incipient to Overt: Angiotensin II Receptor Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study
Makino, H., Haneda, M., Babazono, T., Moriya, T., Ito, S., Iwamoto, Y., Kawamori, R., Takeuchi, M., Katayama, S.Volume:
33
Language:
english
Journal:
Journal of International Medical Research
DOI:
10.1177/147323000503300610
Date:
November, 2005
File:
PDF, 57 KB
english, 2005